Company Overview
About Cleancard
Cleancard is a United States-based at-home cancer screening company — backed by Y Combinator (S23) with $846,000 in total funding from Mayo Clinic Platform, TQ Ventures, Urban Innovation Fund, Y Combinator, and the Creative Destruction Lab — developing a 30-minute at-home diagnostic platform that combines synthetic biology, machine learning, and computer vision to detect multiple cancer biomarkers from a single patient sample for prostate, bladder, and ovarian cancers. Founded by Luca Springer and Thomas Carroll (both Rhodes Scholars from Oxford), Cleancard targets the massive unmet need for accessible, affordable cancer screening outside of clinical settings — the 30-minute result time and home-based format enabling screening at the frequency and convenience required for early cancer detection programs.
Business Model & Competitive Advantage
Cleancard's at-home cancer screening technology addresses the access and adherence barriers that reduce the effectiveness of existing cancer screening programs: prostate-specific antigen (PSA) testing, bladder cancer urine cytology, and ovarian cancer CA-125 testing are all clinic-based procedures that require scheduling appointments, traveling to labs, and waiting days for results — friction that causes eligible patients to skip routine screening or delay follow-up after abnormal results. Cleancard's platform uses synthetic biology-engineered biosensors (designed to detect specific cancer biomarker proteins or genetic signatures in urine or blood samples) combined with computer vision analysis of the test result pattern (reading the quantitative biomarker level from the test strip or cartridge format) to deliver clinical-grade sensitivity and specificity in a consumer-facing format. The multiplexable format (detecting multiple cancer biomarkers from a single sample) enables panel testing that improves early detection probability compared to single-marker testing — a key advance over current single-analyte home tests. Mayo Clinic Platform's investment provides the clinical validation infrastructure and healthcare system distribution relationships that consumer diagnostic companies require for clinical adoption.
Competitive Landscape 2025–2026
In 2025, Cleancard competes in the at-home diagnostics, cancer screening, and consumer health testing market with Galleri (Illumina/GRAIL multi-cancer early detection liquid biopsy, $1.9B raised), Exact Sciences (NASDAQ: EXAS, Cologuard colorectal cancer screening, $1B revenue), and EarlySign (AI-based early cancer detection, $21M raised) for consumer and healthcare system early cancer detection platform adoption. Mayo Clinic Platform's partnership (Mayo Clinic is one of the world's most trusted healthcare institutions) provides clinical validation credibility critical for consumer cancer diagnostic adoption where clinical trust is paramount. Rhodes Scholar founding team backgrounds reflect the academic research rigor that translates synthetic biology biosensor research into manufacturable consumer diagnostic products. The 2025 strategy focuses on achieving clinical validation data for the prostate and bladder cancer panels, pursuing FDA 510(k) clearance for at-home use authorization, and building the telehealth follow-up pathway for patients with positive screening results.
Recent Activity
View all →Key Differentiators
Emerging Innovator
Cleancard is an emerging player bringing innovative solutions to the Healthcare market.
Frequently Asked Questions
Estimated Visibility Trend (Beta)
Simulated 8-week rolling score
Based on estimated brand signals. Historical tracking coming soon.
Similar Brands
Browser Use
Browser Use is an open-source project that provides a Python library allowing AI agents and large language models to control web browsers as a tool. The library sits between LLM APIs and browser autom
Oracle Health
Oracle Health is the healthcare technology business unit of Oracle Corporation (NYSE: ORCL) — providing electronic health records (EHR), clinical workflow management, health information exchange, reve
athenahealth
athenahealth is a cloud-based electronic health records (EHR), medical billing, and practice management company founded in 1997 and headquartered in Watertown, Massachusetts. The company was built on
Veeva Systems
Veeva Systems Inc. is the leading cloud software provider for the global life sciences industry, headquartered in Pleasanton, California. Founded in 2007 by Peter Gassner (a former Salesforce executiv
Idexx Laboratories
IDEXX Laboratories is the global leader in veterinary diagnostics and information technology for companion animal healthcare, founded in 1983 by David Shaw in Westbrook, Maine, where it remains headqu
Revvity
Revvity, Inc. (formerly PerkinElmer) is a global life science tools and diagnostics company, rebranded in 2023 to signal its transformation from a diversified instruments company into a focused provid
Compare Cleancard with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Cleancard? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Cleancard Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Cleancard vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →